View in EDS

Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions.

Saved in:
Bibliographic Details
Title: Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions.
Authors: Damelin M; Pfizer, Inc., Pearl River, New York. scott.dylla@stemcentrx.com marc.damelin@pfizer.com., Bankovich A; Stemcentrx, Inc., South San Francisco, California., Park A; Stemcentrx, Inc., South San Francisco, California., Aguilar J; Stemcentrx, Inc., South San Francisco, California., Anderson W; Stemcentrx, Inc., South San Francisco, California., Santaguida M; Stemcentrx, Inc., South San Francisco, California., Aujay M; Stemcentrx, Inc., South San Francisco, California., Fong S; Stemcentrx, Inc., South San Francisco, California., Khandke K; Pfizer, Inc., Pearl River, New York., Pulito V; Pfizer, Inc., Pearl River, New York., Ernstoff E; Pfizer, Inc., Pearl River, New York., Escarpe P; Stemcentrx, Inc., South San Francisco, California., Bernstein J; Stemcentrx, Inc., South San Francisco, California., Pysz M; Stemcentrx, Inc., South San Francisco, California., Zhong W; Pfizer, Inc., Pearl River, New York., Upeslacis E; Pfizer, Inc., Pearl River, New York., Lucas J; Pfizer, Inc., Pearl River, New York., Lucas J; Pfizer, Inc., Pearl River, New York., Nichols T; Pfizer, Inc., Pearl River, New York., Loving K; Stemcentrx, Inc., South San Francisco, California., Foord O; Stemcentrx, Inc., South San Francisco, California., Hampl J; Stemcentrx, Inc., South San Francisco, California., Stull R; Stemcentrx, Inc., South San Francisco, California., Barletta F; Pfizer, Inc., Pearl River, New York., Falahatpisheh H; Pfizer, Inc., Pearl River, New York., Sapra P; Pfizer, Inc., Pearl River, New York., Gerber HP; Pfizer, Inc., Pearl River, New York., Dylla SJ; Stemcentrx, Inc., South San Francisco, California. scott.dylla@stemcentrx.com marc.damelin@pfizer.com.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2015 Sep 15; Vol. 21 (18), pp. 4165-73. Date of Electronic Publication: 2015 May 26.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 26015513
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Damelin+M%22">Damelin M</searchLink>; Pfizer, Inc., Pearl River, New York. scott.dylla@stemcentrx.com marc.damelin@pfizer.com.<br /><searchLink fieldCode="AU" term="%22Bankovich+A%22">Bankovich A</searchLink>; Stemcentrx, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Park+A%22">Park A</searchLink>; Stemcentrx, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Aguilar+J%22">Aguilar J</searchLink>; Stemcentrx, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Anderson+W%22">Anderson W</searchLink>; Stemcentrx, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Santaguida+M%22">Santaguida M</searchLink>; Stemcentrx, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Aujay+M%22">Aujay M</searchLink>; Stemcentrx, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Fong+S%22">Fong S</searchLink>; Stemcentrx, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Khandke+K%22">Khandke K</searchLink>; Pfizer, Inc., Pearl River, New York.<br /><searchLink fieldCode="AU" term="%22Pulito+V%22">Pulito V</searchLink>; Pfizer, Inc., Pearl River, New York.<br /><searchLink fieldCode="AU" term="%22Ernstoff+E%22">Ernstoff E</searchLink>; Pfizer, Inc., Pearl River, New York.<br /><searchLink fieldCode="AU" term="%22Escarpe+P%22">Escarpe P</searchLink>; Stemcentrx, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Bernstein+J%22">Bernstein J</searchLink>; Stemcentrx, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Pysz+M%22">Pysz M</searchLink>; Stemcentrx, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Zhong+W%22">Zhong W</searchLink>; Pfizer, Inc., Pearl River, New York.<br /><searchLink fieldCode="AU" term="%22Upeslacis+E%22">Upeslacis E</searchLink>; Pfizer, Inc., Pearl River, New York.<br /><searchLink fieldCode="AU" term="%22Lucas+J%22">Lucas J</searchLink>; Pfizer, Inc., Pearl River, New York.<br /><searchLink fieldCode="AU" term="%22Lucas+J%22">Lucas J</searchLink>; Pfizer, Inc., Pearl River, New York.<br /><searchLink fieldCode="AU" term="%22Nichols+T%22">Nichols T</searchLink>; Pfizer, Inc., Pearl River, New York.<br /><searchLink fieldCode="AU" term="%22Loving+K%22">Loving K</searchLink>; Stemcentrx, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Foord+O%22">Foord O</searchLink>; Stemcentrx, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Hampl+J%22">Hampl J</searchLink>; Stemcentrx, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Stull+R%22">Stull R</searchLink>; Stemcentrx, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Barletta+F%22">Barletta F</searchLink>; Pfizer, Inc., Pearl River, New York.<br /><searchLink fieldCode="AU" term="%22Falahatpisheh+H%22">Falahatpisheh H</searchLink>; Pfizer, Inc., Pearl River, New York.<br /><searchLink fieldCode="AU" term="%22Sapra+P%22">Sapra P</searchLink>; Pfizer, Inc., Pearl River, New York.<br /><searchLink fieldCode="AU" term="%22Gerber+HP%22">Gerber HP</searchLink>; Pfizer, Inc., Pearl River, New York.<br /><searchLink fieldCode="AU" term="%22Dylla+SJ%22">Dylla SJ</searchLink>; Stemcentrx, Inc., South San Francisco, California. scott.dylla@stemcentrx.com marc.damelin@pfizer.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2015 Sep 15; Vol. 21 (18), pp. 4165-73. <i>Date of Electronic Publication: </i>2015 May 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26015513
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1078-0432.CCR-15-0695
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4165
    Titles:
      – TitleFull: Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Damelin M
      – PersonEntity:
          Name:
            NameFull: Bankovich A
      – PersonEntity:
          Name:
            NameFull: Park A
      – PersonEntity:
          Name:
            NameFull: Aguilar J
      – PersonEntity:
          Name:
            NameFull: Anderson W
      – PersonEntity:
          Name:
            NameFull: Santaguida M
      – PersonEntity:
          Name:
            NameFull: Aujay M
      – PersonEntity:
          Name:
            NameFull: Fong S
      – PersonEntity:
          Name:
            NameFull: Khandke K
      – PersonEntity:
          Name:
            NameFull: Pulito V
      – PersonEntity:
          Name:
            NameFull: Ernstoff E
      – PersonEntity:
          Name:
            NameFull: Escarpe P
      – PersonEntity:
          Name:
            NameFull: Bernstein J
      – PersonEntity:
          Name:
            NameFull: Pysz M
      – PersonEntity:
          Name:
            NameFull: Zhong W
      – PersonEntity:
          Name:
            NameFull: Upeslacis E
      – PersonEntity:
          Name:
            NameFull: Lucas J
      – PersonEntity:
          Name:
            NameFull: Lucas J
      – PersonEntity:
          Name:
            NameFull: Nichols T
      – PersonEntity:
          Name:
            NameFull: Loving K
      – PersonEntity:
          Name:
            NameFull: Foord O
      – PersonEntity:
          Name:
            NameFull: Hampl J
      – PersonEntity:
          Name:
            NameFull: Stull R
      – PersonEntity:
          Name:
            NameFull: Barletta F
      – PersonEntity:
          Name:
            NameFull: Falahatpisheh H
      – PersonEntity:
          Name:
            NameFull: Sapra P
      – PersonEntity:
          Name:
            NameFull: Gerber HP
      – PersonEntity:
          Name:
            NameFull: Dylla SJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 09
              Text: 2015 Sep 15
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-electronic
              Value: 1557-3265
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 18
          Titles:
            – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research
              Type: main
ResultId 1